As a leader in Named Patient Medicines, Kempex supplies Chinese and Indian pharmaceuticals to countries where the medicines would not otherwise be available, giving health professionals and their patients additional options for healing and wellness.

The impact is far-reaching, not only for the patients we serve but also for the manufacturers of the medicines we supply.

For the manufacturer, our program primes new markets, creating sales and demand without the usual marketing costs, and it helps manufacturers gain the clinical experience and support of international Key Opinion Leaders (KOLs).

For the importing facility, our program creates an individual profile to meet the specific needs of each customer’s import process for prompt delivery of medicines to the patient.

Such a mutually beneficial program demands careful management and meticulous compliance with the regulatory requirements of every country in which we operate. It requires expertise in pharmaceutical export, distribution, security, regulatory oversight, and transparency.

For more than 5 years, Kempex has successfully balanced the needs of doctors, patients, and manufacturers to serve the interests of health care around the world.

Kempex Holland BV's future plans have three distinct issues which are as follows

Kempex Holland BV is a customer-centric company. This means whatever we do, we plunge at it from the customer’s point of view- and this is reflected in our vision and values. While our vision defines the ultimate goal we wish to pursue for our customers, our core values serve as a road map that guides our daily decision-making policy.

 

1. Consolidates current business:

The Kempex Holland BV enjoys an excellent reputation amongst its suppliers and buyers as a trustworthy and reliable business partner. Kempex Holland BV plans to consolidate its market share in the Chinese pharmaceutical products and other current product markets and increase its profitability.

2. Add new products in the current market:

Kempex Holland BV is very strong in the Indian Market. With its key personnel belonging to India, it plans to add new products to its portfolio such as Pharmaceutical intermediaries.

3. Add new markets:

Kempex Holland BV focuses on Mainland China & European Union as two exciting new markets in the current year. Kempex Holland BV is very actively pursuing new customers in the domain of pharmaceutical herbal and nutraceutical products in the EU.